Research Committee
Background
With the progressive growth of AFLAR and the realisation of the magnitude of organisational potentials in the wake of the COVID-19 pandemic and the possibilities for the future, AFLAR recognises the need for a research committee to spearhead the growth and spread of rheumatology research and rheumatology research culture across the continent. The research committee will be saddled with developing and co-ordinating research initiatives in the field of rheumatology across the countries represented in the AFLAR network. This committee is currently led by Dr. Hakeem Olaosebikan. The Committee does not pursue gainful or self-help purposes.
General Provisions
The Research Committee (hereinafter “Committee”) has been established by the Executive committee of the African League of Association for Rheumatology (hereinafter “AFLAR” and the “AFLAR EXCO”) in accordance with the constitution of AFLAR (hereinafter “constitution”). The Committee forms a part of AFLAR and has no legal personality.
Constitution and By-Laws
The Constitution and these by-laws (hereinafter “By-Laws”) shall apply to the Committee. In case of conflict between the provisions of the Constitution and the ones of these By-Laws, the provisions of the Constitution shall prevail.
Objectives
The Committee supports AFLAR ‘s aims to reduce the impact of rheumatic and musculoskeletal diseases (RMDs) on the individual and society and to improve the social position and the quality of life of people with rheumatic and musculoskeletal diseases in Africa.
Focus
In furtherance of these aims, the Committee focuses on the activities in the field of Research, in particular:
a) Encourage and facilitate rheumatology research in Africa
b) Support and promotion of research initiatives within member associations;
c) Coordination of the work of its Sub-Committees
